Patients who undergo physical therapy soon after a pain diagnosis are less likely to use opioids in the long term, a Stanford-Duke study finds.
Two leaders of Stanford’s Presence Center — Abraham Verghese and Sonoo Thadaney Israni — explore how AI can enhance the human side of patient care.
Young people prescribed opioids by dental providers were at increased risk of developing opioid addiction in the following year, a Stanford study found.
Sharon Chinthrajah weighs in on a new peanut allergy immunotherapy, speaking to its potential and its role in the future of food allergies therapy.
An anti-smoking ad campaign featuring a woman with depression helps smokers with mental health conditions attempt to quit.
A government program providing market-value, noncash compensation to kidney donors would benefit poor people and not be exploitative, according to a study.
Scientists create algorithms that read X-rays and MRIs in an effort to enhance doctor's diagnoses of certain disease and injury.
A Stanford team has developed an algorithm that uses data about tumors to identify new classifications that can provide information about patient outcomes
In this radio show, Stanford bioethicist David Magnus and host Russ Altman discuss the ethical implications of using AI in health care.
The anti-inflammatory drug ketoprofen shows promise as effective medical treatment for lymphedema symptoms, small Stanford study finds
Decision scientist Mehlika Toy is working with the WHO to help eliminate the public health burden of hepatitis B by the year 2030.
A study led by a Stanford Business researcher at four schools in Panama explores the best way to persuade kids to drink more water.
Scientists have measured the human “exposome,” or the particulates, chemicals, and microbes that individually swarm us all, in unprecedented detail.
At the Global Climate Action Summit recently, Stanford researchers emphasized the importance of the effects of climate change on children's health.
Stanford physician Donna Zulman is working to understand why high-need patients may not follow-up with care outside the clinic.
Targeted screening can cut hepatitis B related deaths in the U.S. by half - and save money.
